Your browser doesn't support javascript.
loading
The Chemical Biology of NO that Regulates Oncogenic Signaling and Metabolism: NOS2 and Its Role in Inflammatory Disease.
Miranda, Katrina M; Ridnour, Lisa A; Cheng, Robert Y S; Wink, David A; Thomas, Douglas D.
Afiliação
  • Miranda KM; Department of Chemistry, University of Arizona, Tucson, Arizona.
  • Ridnour LA; Laboratory of Cancer Immunometabolism, National Cancer Institute, Frederick, Maryland.
  • Cheng RYS; Laboratory of Cancer Immunometabolism, National Cancer Institute, Frederick, Maryland.
  • Wink DA; Cancer and Inflammation Program, Laboratory of Cancer Immunometabolism, National Cancer Institute, Frederick, Maryland.
  • Thomas DD; Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois.
Crit Rev Oncog ; 28(1): 27-45, 2023.
Article em En | MEDLINE | ID: mdl-37824385
ABSTRACT
Nitric oxide (NO) and the enzyme that synthesizes it, nitric oxide synthase 2 (NOS2), have emerged as key players in inflammation and cancer. Expression of NOS2 in tumors has been correlated both with positive outcomes and with poor prognoses. The chemistry of NO is the major determinate to the biological outcome and the concentration of NO, which can range over five orders of magnitude, is critical in determining which pathways are activated. It is the activation of specific oncogenic and immunological mechanisms that shape the outcome. The kinetics of specific reactions determine the mechanisms of action. In this review, the relevant reactions of NO and related species are discussed with respect to these oncogenic and immunological signals.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Óxido Nítrico Sintase Tipo II / Neoplasias / Óxido Nítrico Limite: Humans Idioma: En Revista: Crit Rev Oncog Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Óxido Nítrico Sintase Tipo II / Neoplasias / Óxido Nítrico Limite: Humans Idioma: En Revista: Crit Rev Oncog Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article